Cite

HARVARD Citation

    Wu, Y. et al. (2021). Management Decisions in Crohn's Disease Are Changed by Knowledge of Proactive and Reactive Testing of Antitumor Necrosis Factor Drug Levels. Crohn's & colitis 360. 3 (3), p. . [Online]. 
  
Back to record